Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 111 - 120 of 236 for mr. (0.07 seconds)

CBT 200 Continues to Bounce Off Its Lows. More details...
A Big Week For Biotech, Which Needed It. More details...
To Nobody's Surprise, Tysabri Effective Against MS. More...
Drug and Biotech Rally on Good News. More details...
Disease Maims and Kills, But Gets No Attention. More...
CBT 200 Stays Flat, Thanks To Genentech. More details...
The Company Faces a Difficult Year But Recovery Is in the...
Which Biotech Company Has the Biggest Market Cap?. More...
A Billion Dollar Opportunity in Monitoring Health Status....
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital